LongLarf

A biocatalytic thionation method is presented for the enantioselective synthesis of thiiranes from epoxides by a halohydrin dehalogenase catalyzed kinetic resolution approach using thiocyanate as a sulfur donor. Various chiral thiiranes bearing aryl and alkyl substituents were synthesized in good yields and enantioselectivities by using recombinant Escherichia coli cells expressing the engineered halohydrin dehalogenase HHDHapb variants.

Abstract

Expanding the enzymatic toolbox for the green synthesis of valuable molecules is still of high interest in synthetic chemistry and the pharmaceutical industry. Chiral thiiranes are valuable sulfur-containing heterocyclic compounds, but relevant methods for their enantioselective synthesis are limited. Herein, we report a biocatalytic thionation strategy for the enantioselective synthesis of thiiranes, which was developed based on the halohydrin dehalogenase (HHDH)-catalyzed enantioselective ring-opening reaction of epoxides with thiocyanate and a subsequent nonenzymatic rearrangement process. A novel HHDH was identified and engineered for enantioselective biocatalytic thionation of various aryl- and alkyl-substituted epoxides on a preparative scale, affording the corresponding thiiranes in up to 43 % isolated yield and 98 % ee. Large-scale synthesis and useful transformations of chiral thiiranes were also performed to demonstrate the utility and scalability of the biocatalytic thionation strategy.

Nature Chemistry, Published online: 07 November 2022; doi:10.1038/s41557-022-01074-0

By a simple stereoselective condensation with remote chirality control, axial chirality could be introduced to the symmetric anthrone backbones that comprise mostly sp²-hybridized carbons. The generated oxime ether functionality enables their transformation with axial-to-point chirality conversion via Beckmann rearrangement into enantioenriched dibenzo-fused seven-membered N-heterocycles.

Abstract

Anthrones and analogues are structural cores shared by diverse pharmacologically active natural and synthetic compounds. The sp²-rich nature imposes inherent obstruction to introduce stereogenic element onto the tricyclic aromatic backbone. In our pursuit to expand the chemical space of axial chirality, a novel type of axially chiral anthrone-derived skeleton was discovered. This work establishes oxime ether as suitable functionality to furnish axial chirality on symmetric anthrone skeletons through stereoselective condensation of the carbonyl entity with long-range chirality control. The enantioenriched anthrones could be elaborated into dibenzo-fused seven-membered N-heterocycles containing well-defined stereogenic center via Beckmann rearrangement with axial-to-point chirality conversion.

The first method for highly enantioselective Brønsted acid catalyzed Heyns rearrangement reactions, featuring low catalyst loadings, high yields, high enantioselectivities, good functional-group tolerance, and broad substrate scope has been developed. The method is efficient, delivering various chiral amines, including some biologically active molecules.

Abstract

Herein we report the first method for highly enantioselective Brønsted acid catalyzed Heyns rearrangements. These reactions, catalyzed by a chiral spiro phosphoric acid, afforded synthetically valuable chiral α-aryl-α-aminoketones which cannot be obtained by means of previously reported Heyns rearrangement methods. This method features low catalyst loadings, high yields and high enantioselectivities, making these reactions highly practical. We used the method to efficiently synthesize various chiral amines, including some biologically active molecules. We experimentally proved that these acid-catalyzed Heyns rearrangements proceeded via a proton-transfer process involving an enol intermediate and the stereocontrol was realized during the proton-transfer step.

Publication date: 8 December 2022

Source: Chem, Volume 8, Issue 12

Author(s): Yu Zhang, Tong Zhang, Shoubhik Das

Synthesis
DOI: 10.1055/a-1932-6937

Visible light photocatalysis has established itself as a promising sustainable and powerful strategy to access reactive intermediates, i.e. radicals and radical ions, under mild reaction conditions using visible light irradiation. This field enables the development of formerly challenging or even previously inaccessible organic transformations. In this tutorial review, an overview of the essential concepts and techniques of visible-light-mediated chemical processes and the most common types of photochemical activation of organic molecules, i.e. photoredox catalysis and photosensitization, are discussed. Selected photocatalytic alkene functionalization reactions are included as examples to illustrate the basic concepts and techniques with particular attention given to the understanding of their reaction mechanisms.1 Introduction2 Photocatalysts3 Photophysical and Electrochemical Properties3.1 Excited-State Energy3.2 Ground-State Redox Potentials3.3 Excited-State Redox Potentials3.4 Local Absorbance Maximum for Lowest Energy Absorption3.5 Excited-State Lifetime3.6 [Ru(bpy)3]2+ as a Case Study3.7 Basic Laws and Equations of Photochemistry and Photocatalysis3.8 Common Terminology in Photochemistry and Photocatalysis4 Activation Modes in Photocatalysis4.1 Photoinduced Electron Transfer4.2 Photoinduced Energy Transfer5 Conclusions and Outlook
[...]

Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Article in Thieme eJournals:
Table of contents  |  Abstract  |  Full text

We report in vivo biocatalytic cascade reactions comprising a combination of canonical enzyme-catalysed reactions with an artificial-enzyme-catalysed new-to-nature reaction. The artificial enzyme contains a genetically encoded unnatural catalytic residue, which catalyses the formation of a hydrazone product from biosynthetically produced benzaldehydes in E. coli.

Abstract

Artificial enzymes utilizing the genetically encoded non-proteinogenic amino acid p-aminophenylalanine (pAF) as a catalytic residue are able to react with carbonyl compounds through an iminium ion mechanism to promote reactions that have no equivalent in nature. Herein, we report an in vivo biocatalytic cascade that is augmented with such an artificial enzyme-catalysed new-to-nature reaction. The artificial enzyme in this study is a pAF-containing evolved variant of the lactococcal multidrug-resistance regulator, designated LmrR_V15pAF_RMH, which efficiently converts benzaldehyde derivatives produced in vivo into the corresponding hydrazone products inside E. coli cells. These in vivo biocatalytic cascades comprising an artificial-enzyme-catalysed reaction are an important step towards achieving a hybrid metabolism.

An in vivo selection strategy is presented, in which bacteria addicted to non-canonical amino acids (ncAAs) are complemented by enzymes that can yield these building blocks from synthetic precursors. As growth rates under selective conditions correlate with enzyme activities, serial passaging elicited better biocatalysts from populations harboring enzyme libraries. The platform was used to improve the activity of carbamoylases for ncAA-precursors.

Abstract

In vivo selections are powerful tools for the directed evolution of enzymes. However, the need to link enzymatic activity to cellular survival makes selections for enzymes that do not fulfill a metabolic function challenging. Here, we present an in vivo selection strategy that leverages recoded organisms addicted to non-canonical amino acids (ncAAs) to evolve biocatalysts that can provide these building blocks from synthetic precursors. We exemplify our platform by engineering carbamoylases that display catalytic efficiencies more than five orders of magnitude higher than those observed for the wild-type enzyme for ncAA-precursors. As growth rates of bacteria under selective conditions correlate with enzymatic activities, we were able to elicit improved variants from populations by performing serial passaging. By requiring minimal human intervention and no specialized equipment, we surmise that our strategy will become a versatile tool for the in vivo directed evolution of diverse biocatalysts.

Nature, Published online: 01 November 2022; doi:10.1038/d41586-022-03539-1

Abstract

The compatibility between gold(I) catalysts and amine transaminases has been explored to transform racemic propargylic alcohols into enantioenriched allylic amines in a straightforward and selective manner. The synthetic approach consists of a gold(I)-catalysed Meyer-Schuster rearrangement of a series of 2-arylpent-3-yn-2-ols and a subsequent stereoselective enzyme-catalysed transamination of the resulting α,β-unsaturated prochiral ketones. The design of cascade processes involving sequential or concurrent approaches has been studied in our search for ideal reaction conditions to produce the desired amines. Thus, the N-heterocyclic carbene complex [1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]-[bis(trifluoromethanesulfonyl)-imide]gold(I) ([Au(IPr)(NTf₂)] (A) in aqueous medium was found to be an ideal catalyst, while selective, made-in-house and commercial amine transaminases permitted the asymmetric synthesis of both (E)-4-arylpent-3-en-2-amine enantiomers in good isolated yields (53–84%) and excellent stereoselectivities (97 to >99% enantiomeric excess).

Why does biochemical amino acid synthesis proceed the way it does? Kinetic and mechanistic experiments with a model hydride donor were used to determine the intrinsic electrophilic reactivities of keto acids in reduction and reductive amination reactions. Comparing the nonenzymatic reactivity trends with those found in biology provides new insight into the structure of amino acid metabolism.

Abstract

Amino acid biosynthesis initiates with the reductive amination of α-ketoglutarate with ammonia to produce glutamate. However, the other α-keto acids derived from the glyoxylate and Krebs cycles are converted into amino acids by transamination, rather than by reductive amination. Why is only one amino acid synthesized by reductive amination and not the others? To explore this question, we quantified the inherent reactivities of keto acids in nonenzymatic reduction and reductive amination by using BH₃CN⁻ as a model nucleophile. Biological α-keto acids were found to show pronounced nonenzymatic reactivity differences for the formation of amino acids (α-ketoglutarate<oxaloacetate≈pyruvate≪glyoxylate). Accordingly, the flow of ammonia passes through the least reactive α-keto acid of the Krebs cycle. One possible explanation for this choice is the position of the corresponding amino acid, glutamate, at the top of the thermodynamic landscape for subsequent transamination reactions.

Self-assembled protein cages were functionalized to achieve spatial organization of sequential enzymes in living cells, which confer cascade reactions with optimal local concentrations and microenvironment, thereby entailing enhanced biocatalytic performance.

Abstract

Cells use self-assembled biomaterials such as lipid membranes or proteinaceous shells to coordinate thousands of reactions that simultaneously take place within crowded spaces. However, mimicking such spatial organization for synthetic applications in engineered systems remains a challenge, resulting in inferior catalytic efficiency. In this work, we show that protein cages as an ideal scaffold to organize enzymes to enhance cascade reactions both in vitro and in living cells. We demonstrate that not only enzyme-enzyme distance but also the improved K _m value contribute to the enhanced reaction rate of cascade reactions. Three sequential enzymes for lycopene biosynthesis have been co-localized on the exterior of the engineered protein cages in Escherichia coli, leading to an 8.5-fold increase of lycopene production by streamlining metabolic flux towards its biosynthesis. This versatile system offers a powerful tool to achieve enzyme spatial organization for broad applications in biocatalysis.